EV/EBITDA:
-9.83-0.02(-0.20%)Summary
- As of today (July 1, 2025), TVTX EV/EBITDA is -9.83, with a fall of -0.02 (-0.20%) during the most recent trading session on June 30, 2025.
- Over the past year, TVTX EV/EBITDA has dropped by -6.83 (-227.67%).
- TVTX EV/EBITDA is now -105.42% below its all-time high of 181.49.
Performance
TVTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TVTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -0.2% | +0.2% | +0.2% |
| 1 m1 month | +1.1% | -1.2% | -1.5% |
| 3 m3 months | - | - | -15.1% |
| 6 m6 months | -40.0% | -11.4% | -15.0% |
| ytdytd | -40.0% | -11.4% | -15.0% |
| 1 y1 year | -227.7% | +66.4% | +78.7% |
| 5 y5 years | +32.4% | +61.1% | -28.5% |
TVTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.45 | -4.0% | -10.21 | +3.7% |
| 3 m | 3-month | -7.86 | -25.1% | -13.38 | +26.5% |
| 6 m | 6-month | -6.96 | -41.2% | -13.38 | +26.5% |
| 1 y | 1-year | -2.99 | -228.8% | -13.38 | +26.5% |
| 3 y | 3-year | -2.05 | -379.5% | -13.38 | +26.5% |
| 5 y | 5-year | -2.05 | -379.5% | -26.18 | +62.5% |
| alltime | all time | 181.49 | -105.4% | -5339 | +99.8% |
TVTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -9.83(+40.0%) |
| 2024 | -7.02(+123.6%) |
| 2023 | -3.14(-60.4%) |
| 2022 | -7.93(-48.2%) |
| 2021 | -15.32(+40.4%) |
| 2020 | -10.91(+55.0%) |
| 2019 | -7.04(-50.8%) |
| Date | Value |
|---|---|
| 2018 | -14.31(-29.9%) |
| 2017 | -20.40(+3.9%) |
| 2016 | -19.64(-450.7%) |
| 2015 | 5.60(-130.3%) |
| 2014 | -18.48(+141.3%) |
| 2013 | -7.66(-99.7%) |
| 2012 | -2308.72 |
FAQ
- What is Travere Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Travere Therapeutics?
- What is TVTX EV/EBITDA year-to-date change?
- What is Travere Therapeutics EV/EBITDA year-on-year change?
What is Travere Therapeutics EV/EBITDA?
The current EV/EBITDA of TVTX is -9.83
What is the all time high EV/EBITDA for Travere Therapeutics?
Travere Therapeutics all-time high EV/EBITDA is 181.49
What is TVTX EV/EBITDA year-to-date change?
Travere Therapeutics EV/EBITDA has changed by -2.81 (-40.03%) since the beginning of the year
What is Travere Therapeutics EV/EBITDA year-on-year change?
Over the past year, TVTX EV/EBITDA has changed by -6.83 (-227.67%)